| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.3B | $5.1B | $4.7B | $4.3B | $3.8B | $3.6B | $0.7B | $0.8B |
| Cost of Revenue | — | — | — | — | — | — | — | $1.1B |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.1B | $1.0B | $0.8B | $0.7B | $0.8B | $0.8B | $0.0B | $0.1B |
| Net Income | $0.6B | $0.6B | $0.5B | $0.5B | $0.6B | $0.6B | $0.1B | $0.0B |
| EPS (Basic) | $5.15 | $5.35 | $4.42 | $4.27 | $5.48 | $4.89 | $0.57 | $0.23 |
| EPS (Diluted) | $5.05 | $5.24 | $4.41 | $4.26 | $5.47 | $4.87 | $0.57 | $0.23 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $30.0B | $26.1B | $24.7B | $22.7B | $22.0B | $20.0B | $18.5B | $17.7B |
| Current Assets | $1.7B | $1.7B | $1.9B | $1.8B | $1.6B | $1.2B | $1.0B | $0.9B |
| Cash & Equivalents | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | $0.0B | $0.0B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $3.2B | $2.8B | $2.9B | $1.8B | $1.8B | $1.4B | $2.1B | $1.6B |
| Stockholders' Equity | $7.0B | $6.8B | $6.2B | $6.0B | $5.9B | $5.6B | $5.4B | $5.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $1.6B | $1.2B | $1.2B | $0.9B | $1.0B | $1.0B | $1.3B |
| Investing Cash Flow | $-2.4B | $-1.9B | $-1.7B | $-1.6B | $-1.4B | $-1.3B | $-1.1B | $-1.2B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $0.6B | $0.3B | $0.5B | $0.4B | $0.5B | $0.4B | $0.2B | $-0.1B |